convalescent COVID-19 patient
[용어속성] Term
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens
Research article
[키워드] Anti-spike
Antibody titers
assays
binding domain
Bio-rad
Blood
Canada
collected
Comparative
convalescent COVID-19 patient
COVID-19
COVID-19 pandemic
DBS sample
Direct
Dried blood spots
Elecsy
evaluated
IgG
immunoassays
individual
Infection
Mount Sinai
MSD
multiple antigen
multiplex
observé
Panel
protocols
RBD
resulting
Roche
SARS-CoV-2
SARS-CoV-2 antibody testing
SARS-CoV-2 IgG
sensitivity
Serological assay
serology
Serosurvey
Serosurveys
specificity
specimen
transmitted
university
[DOI] 10.1016/j.heliyon.2022.e10270 [Article Type] Research article
[DOI] 10.1016/j.heliyon.2022.e10270 [Article Type] Research article
Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients
혈장 대사체 및 사이토카인 프로필은 회복기 COVID-19 환자에서 글리실프롤린 조절 항체 퇴색을 나타냅니다
Article
Published on
Journal: Proceedings of the National Academy of Sciences of [Category] SARS, 바이오마커, 진단,
Journal: Proceedings of the National Academy of Sciences of [Category] SARS, 바이오마커, 진단,
[키워드] accumulated
Accuracy
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
alteration
antibody
association
catalyzed
cleavage
conducted
convalescent
convalescent COVID-19 patient
convalescent COVID-19 patients
convalescent patient
Convalescent patients
coronavirus
COVID-19
COVID-19 convalescent patients
COVID-19 pandemic
cytokine
cytokine profile
cytokine profiling
Cytokines
demonstrated
dipeptide
dipeptidyl peptidase
Dipeptidyl peptidase 4
domain
down-regulate
DPP4
experiment
feature
Feature selection
glycylproline
healthy
healthy subjects
IL-12p40
immune response
immune responses
individual
inhibitor
inhibitory effect
Inhibitory effects
M-CSF
machine-learning
mechanism
metabolite
metabolites
metabolome
metabolomics
mice
modulating
neutralizing antibody
outcome
peptide
plasma
Plasma cytokine
product
public health
Quantitative
respiratory
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 vaccination
severe acute respiratory syndrome Coronavirus
sitagliptin
suppresse
therapeutic
Treatment
vaccination
Vaccination strategy
with COVID-19
[DOI] 10.1073/pnas.2117089119 PMC 바로가기 [Article Type] Article
[DOI] 10.1073/pnas.2117089119 PMC 바로가기 [Article Type] Article
Humoral and cellular response in convalescent COVID-19 lupus patients
회복기 COVID-19 루푸스 환자의 체액 및 세포 반응
Article
[키워드] accumulated
adaptive
Analysis
analyzed
antibodies
antibody
Antibody Response
Antibody titer
Antibody titers
CD8
cellular response
changes in
collected
confirmed cases
confirmed COVID-19 case
convalescent
convalescent COVID-19 patient
convalescent COVID-19 patients
convalescent patient
Convalescent patients
COVID-19
COVID-19 disease
COVID-19 incidence
COVID-19 infection
COVID-19 susceptibility
declined
decrease
died
dose
dysregulation
evaluated
flow cytometry
Gene expression analysis
General population
Health care
higher risk
Hospital admission
humoral
Humoral and cellular responses
hypocomplementemia
IgG antibodies
immune dysregulation
immune response
immunological
immunological profile
Immunological studies
Immunosuppression
immunosuppressive
immunosuppressive therapy
impair
incidence
increase in
Infection
intensive care
lack
longitudinal
longitudinal changes
Lupus
medical record
memory cell
Mild
Patient
patients
PBMC
PBMCs
PCR-confirmed COVID-19
Prednisone
predominant
prospective cohort
reduction
required
risk factor
Risk factors
SARS-CoV-2 IgG
SARS-CoV-2 IgG antibodies
SARS-CoV-2 IgG antibody
severe COVID-19 disease
severe disease
severity
Signaling
SLE
Surveillance
susceptibility
sustained
Symptom
symptom onset
T cell
Th17
Th2 response
therapy
were measured
[DOI] 10.1038/s41598-022-17334-5 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-022-17334-5 PMC 바로가기 [Article Type] Article
The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies
수용체 결합 도메인 결합 특이적 인간 단일클론 항체를 사용하여 바이러스에 감염된 세포에서 SARS-CoV-2 스파이크 단백질의 세포 특성화
Article
[키워드] adopted
antibody
appearance
appears
attachment
B cell
B cells
biological properties
biological property
can be used
Cell
cell-to-cell transmission
characterization
conformation
conformational change
convalescent COVID-19 patient
convalescent COVID-19 patients
convalescent patient
convalescent patient serum
Convalescent patients
cytoplasmic
demonstrated
early stage
early stages
electron microscopy
epitope
Epitopes
Evidence
exhibited
FIVE
focus
furin
future therapeutic
Golgi complex
host cell
Human
human monoclonal antibodies
Human monoclonal antibody
immunofluorescence microscopy
immunological
indicated
infected cells
infected with SARS-CoV-2
Infection
Interaction
isolate
isolates
Microscopy
mitigate
MONITOR
monoclonal
new virus
occur
offer
Protein
provided
RBD
reagent
Receptor binding domain
receptor binding domain (RBD)
recognize
required
S protein
S protein cleavage
S protein RBD
SARS- CoV-2
SARS-CoV-2
SARS-CoV-2 clinical isolates
SARS-CoV-2 spike
SARS-CoV-2-infected cell
SARS-CoV-2-infected cells
Singapore
Specific
spike
staining
the RBD
the S protein
therapeutic
These data
Transmission
Vaccine
variant
virus infection
virus particles
virus-infected cell
virus-infected cells
was used
were used
while
[DOI] 10.1128/jvi.00455-22 PMC 바로가기 [Article Type] Article
[DOI] 10.1128/jvi.00455-22 PMC 바로가기 [Article Type] Article
Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing
단일 세포 RNA 시퀀싱으로 밝혀진 COVID-19 회복기 개인의 면역 기능
Article
Published on
Journal: International immunopharmacology [Category] COVID19(2023년), MERS, SARS, 유전자 메커니즘, 진단,
Journal: International immunopharmacology [Category] COVID19(2023년), MERS, SARS, 유전자 메커니즘, 진단,
[키워드] Activation
addition
B cell
B cell subset
B cells
Bioinformatics analysis
biological processe
biological processes
CD4
CD8
Cell
cell receptor
cell-cell adhesion
clonal expansions
Cluster
convalescence
convalescent
convalescent COVID-19 patient
convalescent COVID-19 patients
convalescent individual
convalescent individuals
convalescent patient
Convalescent patients
COVID-19
Critical
declined
decreased expression
differentiation
downregulation
effector memory
feature
function
functions
GNLY
HLA class I
HLA class II
HLA class II genes
humoral immune response
Humoral immunity
immune protection
immune response
immune responses
increased expression
infections
Innate
innate immune responses
Innate immunity
Interferon-gamma
involved
leukocyte
mapped
marginal zone
mechanism
Migration
moderate
natural infection
neutrophil
Peripheral blood
peripheral blood samples
phenotypic
reflected
Regulation
Reinfection
retained
RNA
SARS-CoV-2
SARS-CoV-2-specific immune response
SARS-CoV-2-specific immune responses
severe cases
single cell RNA sequencing
Single-cell RNA sequencing
subjects
subset
sustained
T cell
T cell activation
T cell response
T/B cell receptor repertoire.
TCR
upregulation
was increased
weakened
with COVID-19
zone
[DOI] 10.1016/j.intimp.2022.108767 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.intimp.2022.108767 PMC 바로가기 [Article Type] Article
Helminth antigens differentially modulate the activation of CD4 + and CD8 + T lymphocytes of convalescent COVID-19 patients in vitro
기생충 항원은 시험관 내에서 회복기 COVID-19 환자의 CD4 + 및 CD8 + T 림프구의 활성화를 차등적으로 조절합니다
Article
[키워드] Activation
activation markers.
addition
African
age
analyzed
Antigen
antigens
Ascaris lumbricoides
Brugia malayi
caused
CD137
CD137 (4-1BB)
CD4
CD4+
CD4+ helper and CD8+ T cytotoxic T cells
CD69
CD8
CD8+
cell culture supernatants
cell-mediated immune response
convalescent COVID-19 patient
coronavirus
coronavirus disease
Coronavirus disease 2019
country
Course
COVID-19
COVID-19 patient
COVID-19 patients
cytokine expression
Cytotoxic T cell
Cytotoxic T cells
death
Disease progression
Effect
Endemic
evade
expression
Factors
flow cytometry
Frequency
genetics
helminth
Helminth antigens
helper
human immune response
Hypothesis
IFN-γ
IFNγ
IL-10
IL-6
immune
immune reactivity
immune responses
in vitro
incidence of COVID-19
investigated
mechanisms
moderate
modulate
MONITOR
Mortality
not affected
offer
Onchocerca volvulus
pandemic
parasites
PBMC
PBMCs
peptides
Prevalence
reactivity
reduced
reduction
remained
Respiratory disease
SARS-CoV-2
SARS-CoV-2 peptide
SARS-CoV-2 peptides
SARS-CoV-2 transmission
significantly
significantly increased
Spread
Stimulation
sub-Saharan Africa
Support
suppress
T cell
T cell response
T cells
T helper cells
T lymphocyte
TNFα
Vaccines
virus
was measured
were used
[DOI] 10.1186/s12916-022-02441-x PMC 바로가기 [Article Type] Article
[DOI] 10.1186/s12916-022-02441-x PMC 바로가기 [Article Type] Article
Salivary antibodies are detected with a commercial anti-SARS-CoV-2 assay only after two doses of vaccine using serum thresholds
타액 항체는 혈청 역치를 사용하여 백신을 2회 접종한 후에만 상용 항-SARS-CoV-2 분석으로 검출됩니다.
Article
[키워드] anti-SARS-CoV-2
anti-SARS-CoV-2 antibodies
anti-SARS-CoV-2 antibody
Anti-spike
antibody
antibody assay
BNT162b2
BNT162b2 vaccine
Cohort
collected
convalescent COVID-19 patient
COVID-19
COVID-19 serology
declined
detect
dose
feasibility
first dose
Matched
nucleic acid
of BNT162b2
Pfizer-BioNTech
Quantitative
receiving
Roche Diagnostics
Saliva
saliva samples
salivary
SARS-CoV-2
second dose
serology
serum
Serum level
serum levels
single dose
specimen
Surveillance
tested
These data
threshold
thresholds
Total
U/mL
vaccination
Vaccine
vaccine dose
Volunteer
[DOI] 10.1016/j.clinbiochem.2022.02.002 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.clinbiochem.2022.02.002 PMC 바로가기 [Article Type] Article
Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients
Research
[키워드] Adaptive immune response
Analysis
association
blood sample
Characteristics
chronic illnesses
Clinical data
collected
contribute
convalescent COVID-19 patient
convalescent patient
COVID-19 patient
diagnosis of SARS-CoV-2
Health
heterogeneity
Hong Kong
Infection
initial
laboratory data
latent class
neutralising antibody
occur
Older
Patient
performed
Prevent
Re-infection
Regression model
Result
risk
SARS-CoV-2
SARS-COV-2 infection
Seroconversion
subject
subsequent
surveillance data
sVNT
symptomatic
symptomatic patient
Symptomatic patients
tested
the SARS-CoV-2
trajectory
Vaccination strategy
Variability
virus clearance
Virus neutralisation
were measured
[DOI] 10.1038/s43856-022-00119-2 [Article Type] Research
[DOI] 10.1038/s43856-022-00119-2 [Article Type] Research
Peripheral Neuropathy in Patients Recovering from Severe COVID-19: A Case Series
중증 COVID-19에서 회복 중인 환자의 말초 신경병증: 사례 시리즈
Article
[키워드] age
alteration
Care
chronic disease
comparison
convalescent COVID-19 patient
convalescent COVID-19 patients
convalescent phase
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
disability
discharge
enrolled
evaluate
exercise
Exercise capacity
for inclusion
In-hospital
males
manifestation
material
Mononeuropathy
nervous system
neurological manifestations
Neuropathy
nine
objective
occupational medicine
outcome
participant
Patient
patients
peripheral
Peripheral nervous system
Peroneal nerve
Polyneuropathy
Prevalence
proportion
pulmonary
Pulmonary function
pulmonary rehabilitation
rehabilitation
reported
Result
risk
SARS-CoV-2
screened
Sery
severity
significant difference
study groups
unit
[DOI] 10.3390/medicina58040523 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/medicina58040523 PMC 바로가기 [Article Type] Article